Stockholders' equity: Series E convertible preferred stock, $0.001 par value, 200,000 shares authorized, 47,840 shares issued and outstanding at December 31, 2024 and September 30, 2024, with a liquidation preference of $0.30 per share outstanding -- -- Common stock, $0.001 par value, 10,000,000 shares authorized, 3,115,674 and 3,131,360 shares issued and outstanding at December 31, 2024 and September 30, 2024, respectively 2 2 Paid in capital 69,743 69,692 Treasury stock common 710,373 and 694,687 shares as of December 31, 2024 and September 30, 2024, respectively (9,229) (9,072) Treasury stock Series E preferred 80,000 shares as of December 31, 2024 and September 30, 2024 (7) (7) Retained earnings 12,766 12,274 -------------- -------------- Total stockholders' equity 73,275 72,889 Total liabilities and stockholders' equity $ 395,524 $ 407,547 ============== ==============
LIVE VENTURES, INCORPORATED
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(dollars in thousands, except per share)
For the Three Months Ended December 31, ------------------------------------------------- 2024 2023 ---------------- Revenue $ 111,508 $ 117,593 Cost of revenue 76,146 81,266 ---------------- ---------------- Gross profit 35,362 36,327 ---------------- ---------------- Operating expenses: General and administrative expenses 30,071 27,679 Sales and marketing expenses 4,529 5,107 ---------------- ---------------- Total operating expenses 34,600 32,786 ---------------- ---------------- Operating income 762 3,541 Other expense: Interest expense, net (4,162) (4,163) Gain on settlement of seller notes 713 -- Gain on settlement of earnout liability 2,840 -- Other income (expense) 420 (284) ---------------- ---------------- Total other expense, net (189) (4,447) ---------------- ---------------- Income (loss) before provision for income taxes 573 (906) Provision (benefit) for income taxes 81 (224) ---------------- ---------------- Net Income (loss) $ 492 $ (682) ================ ================ Income (loss) per share: Basic and diluted $ 0.16 $ (0.22) Weighted average common shares outstanding: Basic 3,124,581 3,163,541 Diluted 3,124,820 3,163,541
LIVE VENTURES INCORPORATED
NON-GAAP MEASURES RECONCILIATION
Adjusted EBITDA
The following table provides a reconciliation of Net (loss) income to total Adjusted EBITDA(1) for the periods indicated (dollars in thousands):
For the Three Months Ended ---------------------------------------------- December 31, 2024 December 31, 2023 ----------------------- --------------------- Net income (loss) $ 492 $ (682) Depreciation and amortization 4,415 4,295 Stock-based compensation 50 50 Interest expense, net 4,162 4,163 Income tax expense (benefit) 81 (224) Debt refinancing costs -- 183 Gain on extinguishment of debt (713) -- Gain on write-off of earnout (2,840) -- Acquisition costs 97 406 Adjusted EBITDA $ 5,744 $ 8,696 ==== ============= === ============
(END) Dow Jones Newswires
February 06, 2025 08:30 ET (13:30 GMT)
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。